No Data
No Data
Traws Pharma | 10-K: Annual report
Traws Pharma Reports 2024 Financial Results and CEO Change
Traws Pharma Reports FY24 EPS ($35.21)
Express News | Traws Pharma Inc - Cash Runway to Support Operations Into Q1 2026
Traws Pharma: Cash, Cash Equivalents, Short-Term Investments of About $21.3M As of Dec 31 >TRAW
Traws Pharma 2024 Loss/Shr $35.21 >TRAW